tiprankstipranks
Trending News
More News >
Beta Bionics, Inc. (BBNX)
NASDAQ:BBNX
US Market
Advertisement

Beta Bionics, Inc. (BBNX) Financial Statements

Compare
21 Followers

Beta Bionics, Inc. Financial Overview

Beta Bionics, Inc.'s market cap is currently $796.81M. The company's EPS TTM is $-0.39; its P/E ratio is ―; Beta Bionics, Inc. is scheduled to report earnings on July 29, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 65.12M$ 11.99M$ 179.00K
Gross Profit$ 35.89M$ 6.31M$ 179.00K
Operating Income$ -45.25M$ -35.85M$ -65.84M
EBITDA$ -44.10M$ -34.62M$ -63.40M
Net Income$ -54.76M$ -44.10M$ -64.75M
Balance Sheet
Cash & Short-Term Investments$ 103.58M$ 96.75M$ 27.68M
Total Assets$ 149.65M$ 110.04M$ 35.53M
Total Debt$ 7.25M$ 4.22M$ 4.13M
Net Debt$ -23.18M$ -22.34M$ -23.54M
Total Liabilities$ 73.63M$ 51.43M$ 22.53M
Stockholders' Equity$ 76.01M$ 58.61M$ 13.00M
Cash Flow
Free Cash Flow$ -51.67M$ -32.85M$ -60.98M
Operating Cash Flow$ -48.27M$ -32.45M$ -60.21M
Investing Cash Flow$ -3.48M$ -69.69M$ -769.00K
Financing Cash Flow$ 55.62M$ 101.03M$ 56.78M
Currency in USD

Beta Bionics, Inc. Earnings and Revenue History

Beta Bionics, Inc. Debt to Assets

Beta Bionics, Inc. Cash Flow

Beta Bionics, Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis